Skip to main content
. 2018 May 15;9(37):24837–24856. doi: 10.18632/oncotarget.24984

Table 2. Clinical information about how could be recommended the use of G. lucidum and G. frondosa in hormone dependent and triple negative breast cancer patients.

Mushroom Breast cancer (hormone dependent) Breast cancer (triple negative)
G. lucidum +++ ?
G. frondosa + ?

+++ strongly recommended; + recommended, but need to watch out for possible depressive immune effects in these patients;? no clinical trials found in literature but several mouse models are strongly promising.